|
Lipid and lipoprotein metabolism
Citations 251-260 of 547 total displayed.
|
Past content
(since Jan 1999):
|
- Molecular Cardiology
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
- Paolo Parini, Matthew Davis, Aaron T. Lada, Sandra K. Erickson, Teresa L. Wright, Ulf Gustafsson, Staffan Sahlin, Curt Einarsson, Mats Eriksson, Bo Angelin, Hiroshi Tomoda, Satoshi Omura, Mark C. Willingham, and Lawrence L. Rudel
Circulation 2004;110:2017-2023; published online before print as doi:10.1161/01.CIR.0000143163.76212.0B
[Abstract]
[Full text]
- Basic Science for Clinicians
Genetic Basis of Atherosclerosis: Part II: Clinical Implications
- Aldons J. Lusis, Alan M. Fogelman, and Gregg C. Fonarow
Circulation 2004;110:2066-2071, doi:10.1161/01.CIR.0000143098.98869.F8
[Full text]
- Articles
Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2
- Martin Spiecker, Harald Darius, Thomas Hankeln, Muhidien Soufi, Alexander M. Sattler, Jürgen R. Schaefer, Koichi Node, Jan Börgel, Andreas Mügge, Klaus Lindpaintner, Anika Huesing, Bernhard Maisch, Darryl C. Zeldin, and James K. Liao
Circulation published October 4, 2004, doi:10.1161/01.CIR.0000143832.91812.60
[Abstract]
- Correspondence
Overestimation of Plasma Nonesterified Fatty Acid Concentrations in Heparinized Blood • Response
- Liesbeth Visser, Coert J. Zuurbier, Harry B. van Wezel, Ger J. van der Vusse, Frans J. Hoek, Harold L. Lazar, Carmel A. Fitzgerald, Yusheng Bao, Howard Cabral, Carl A. Apstein, and Stuart R. Chipkin
Circulation 2004;110:e328, doi:10.1161/01.CIR.0000142880.24815.E6
[Full text]
- Basic Science for Clinicians
Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways
- Aldons J. Lusis, Alan M. Fogelman, and Gregg C. Fonarow
Circulation 2004;110:1868-1873, doi:10.1161/01.CIR.0000143041.58692.CC
[Full text]
- Articles
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
- Paolo Parini, Matthew Davis, Aaron T. Lada, Sandra K. Erickson, Teresa L. Wright, Ulf Gustafsson, Staffan Sahlin, Curt Einarsson, Mats Eriksson, Bo Angelin, Hiroshi Tomoda, Satoshi Omura, Mark C. Willingham, and Lawrence L. Rudel
Circulation published September 27, 2004, doi:10.1161/01.CIR.0000143163.76212.0B
[Abstract]
- Coronary Heart Disease
Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease
- Marcello Tonelli, Chris Isles, Gary C. Curhan, Andrew Tonkin, Marc A. Pfeffer, James Shepherd, Frank M. Sacks, Curt Furberg, Stuart M. Cobbe, John Simes, Timothy Craven, and Malcolm West
Circulation 2004;110:1557-1563; published online before print as doi:10.1161/01.CIR.0000143892.84582.60
[Abstract]
[Full text]
- Editorials
Cholesteryl Ester Transfer Protein and Coronary Artery Disease: An Observation With Therapeutic Implications
- Megan L. Wolfe and Daniel J. Rader
Circulation 2004;110:1338-1340, doi:10.1161/01.CIR.0000143047.52724.BB
[Full text]
- Coronary Heart Disease
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
- Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, William J. Sasiela, Michael Szarek, Anders G. Olsson, Gregory G. Schwartz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
Circulation 2004;110:1406-1412; published online before print as doi:10.1161/01.CIR.0000141728.23033.B5
[Abstract]
[Full text]
- Vascular Medicine
Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice
- Jeffrey B. Boord, Kazuhisa Maeda, Liza Makowski, Vladimir R. Babaev, Sergio Fazio, MacRae F. Linton, and Gökhan S. Hotamisligil
Circulation 2004;110:1492-1498; published online before print as doi:10.1161/01.CIR.0000141735.13202.B6
[Abstract]
[Full text]
|
|
